|
1
|
Shaha AR: Implications of prognostic
factors and risk groups in the management of differentiated thyroid
cancer. Laryngoscope. 114:393–402. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kondo T, Ezzat S and Asa SL: Pathogenetic
mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer.
6:292–306. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Derwahl M: Linking stem cells to thyroid
cancer. J Clin Endocrinol Metab. 96:610–613. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Organista-Nava J, Gómez-Gómez Y and
Gariglio P: Embryonic stem cell-specific signature in cervical
cancer. Tumour Biol. 35:1727–1738. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim CF and Dirks PB: Cancer and stem cell
biology: How tightly intertwined? Cell Stem Cell. 3:147–150. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wang Y and Armstrong SA: Cancer:
Inappropriate expression of stem cell programs? Cell Stem Cell.
2:297–299. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gu W, Yeo E, McMillan N and Yu C:
Silencing oncogene expression in cervical cancer stem-like cells
inhibits their cell growth and self-renewal ability. Cancer Gene
Ther. 18:897–905. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Al-Hajj M, Wicha MS, Benito-Hernandez A,
Morrison SJ and Clarke MF: Prospective identification of
tumorigenic breast cancer cells. Proc Natl Acad Sci USA.
100:3983–3988. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Collins AT, Berry PA, Hyde C, Stower MJ
and Maitland NJ: Prospective identification of tumorigenic prostate
cancer stem cells. Cancer Res. 65:10946–10951. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hermann PC, Huber SL, Herrler T, Aicher A,
Ellwart JW, Guba M, Bruns CJ and Heeschen C: Distinct populations
of cancer stem cells determine tumor growth and metastatic activity
in human pancreatic cancer. Cell Stem Cell. 1:313–323. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
O'Brien CA, Pollett A, Gallinger S and
Dick JE: A human colon cancer cell capable of initiating tumour
growth in immunodeficient mice. Nature. 445:106–110. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Schatton T, Murphy GF, Frank NY, Yamaura
K, Waaga-Gasser AM, Gasser M, Zhan Q, Jordan S, Duncan LM,
Weishaupt C, et al: Identification of cells initiating human
melanomas. Nature. 451:345–349. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Singh SK, Hawkins C, Clarke ID, Squire JA,
Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB:
Identification of human brain tumour initiating cells. Nature.
432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Friedman S, Lu M, Schultz A, Thomas D and
Lin RY: CD133+ anaplastic thyroid cancer cells initiate
tumors in immunodeficient mice and are regulated by thyrotropin.
PLoS One. 4:e53952009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Zito G, Richiusa P, Bommarito A, Carissimi
E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato
M, et al: In vitro identification and characterization of CD133
(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell
lines. PLoS One. 3:e35442008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Todaro M, Iovino F, Eterno V, Cammareri P,
Gambara G, Espina V, Gulotta G, Dieli F, Giordano S, De Maria R, et
al: Tumorigenic and metastatic activity of human thyroid cancer
stem cells. Cancer Res. 70:8874–8885. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kreso A and Dick JE: Evolution of the
cancer stem cell model. Cell Stem Cell. 14:275–291. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yang ZJ and Wechsler-Reya RJ: Hit ‘em
where they live: Targeting the cancer stem cell niche. Cancer Cell.
11:3–5. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang Q, Liu H, Xiong H, Liu Z, Wang LE,
Qian J, Muddasani R, Lu V, Tan D, Ajani JA, et al: Polymorphisms at
the microRNA binding-site of the stem cell marker gene CD133 modify
susceptibility to and survival of gastric cancer. Mol Carcinog.
54:449–458. 2015. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wei XD, He J, Gao JX, Wang JY, Ma BJ and
Chen J: Investigation on biological characteristics of
CD133+ cancer stem cells in human laryngeal carcinoma
Hep-2 cell line. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi.
48:578–583. 2013.(In Chinese). PubMed/NCBI
|
|
21
|
Fan X, Chen X, Deng W, Zhong G, Cai Q and
Lin T: Up-regulated microRNA-143 in cancer stem cells
differentiation promotes prostate cancer cells metastasis by
modulating FNDC3B expression. BMC Cancer. 13:612013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bu P, Chen KY, Chen JH, Wang L, Walters J,
Shin YJ, Goerger JP, Sun J, Witherspoon M, Rakhilin N, et al: A
microRNA miR-34a-regulated bimodal switch targets Notch in colon
cancer stem cells. Cell Stem Cell. 12:602–615. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang J, Luo N, Luo Y, Peng Z, Zhang T and
Li S: microRNA-150 inhibits human CD133-positive liver cancer stem
cells through negative regulation of the transcription factor
c-Myb. Int J Oncol. 40:747–756. 2012.PubMed/NCBI
|
|
24
|
Cheng Q, Zhang X, Xu X and Lu X: MiR-618
inhibits anaplastic thyroid cancer by repressing XIAP in one ATC
cell line. Ann Endocrinol (Paris). 75:187–193. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiong Y, Zhang L and Kebebew E: MiR-20a is
upregulated in anaplastic thyroid cancer and targets LIMK1. PLoS
One. 9:e961032014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zhang Y, Yang WQ, Zhu H, Qian YY, Zhou L,
Ren YJ, Ren XC, Zhang L, Liu XP, Liu CG, et al: Regulation of
autophagy by miR-30d impacts sensitivity of anaplastic thyroid
carcinoma to cisplatin. Biochem Pharmacol. 87:562–570. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan L, Huang S, He R, Rong M, Dang Y and
Chen G: Decreased expression and clinical significance of miR-148a
in hepatocellular carcinoma tissues. Eur J Med Res. 19:682014.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xia J, Guo X, Yan J and Deng K: The role
of miR-148a in gastric cancer. J Cancer Res Clin Oncol.
140:1451–1456. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liffers ST, Munding JB, Vogt M, Kuhlmann
JD, Verdoodt B, Nambiar S, Maghnouj A, Mirmohammadsadegh A, Hahn SA
and Tannapfel A: MicroRNA-148a is down-regulated in human
pancreatic ductal adenocarcinomas and regulates cell survival by
targeting CDC25B. Lab Invest. 91:1472–1479. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang H, Li Y, Huang Q, Ren X, Hu H, Sheng
H and Lai M: MiR-148a promotes apoptosis by targeting Bcl-2 in
colorectal cancer. Cell Death Differ. 18:1702–1710. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Shen X, Mizuguchi G, Hamiche A and Wu C: A
chromatin remodelling complex involved in transcription and DNA
processing. Nature. 406:541–544. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Papamichos-Chronakis M, Watanabe S, Rando
OJ and Peterson CL: Global regulation of H2A.Z localization by the
INO80 chromatin-remodeling enzyme is essential for genome
integrity. Cell. 144:200–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Chia NY, Chan YS, Feng B, Lu X, Orlov YL,
Moreau D, Kumar P, Yang L, Jiang J, Lau MS, et al: A genome-wide
RNAi screen reveals determinants of human embryonic stem cell
identity. Nature. 468:316–320. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Hu G, Kim J, Xu Q, Leng Y, Orkin SH and
Elledge SJ: A genome-wide RNAi screen identifies a new
transcriptional module required for self-renewal. Genes Dev.
23:837–848. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Conaway RC and Conaway JW: The INO80
chromatin remodeling complex in transcription, replication and
repair. Trends Biochem Sci. 34:71–77. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Morrison AJ and Shen X: Chromatin
remodelling beyond transcription: The INO80 and SWR1 complexes. Nat
Rev Mol Cell Biol. 10:373–384. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
37
|
Watanabe S and Peterson CL: The INO80
family of chromatin-remodeling enzymes: Regulators of histone
variant dynamics. Cold Spring Harb Symp Quant Biol. 75:35–42. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang L, Du Y, Ward JM, Shimbo T, Lackford
B, Zheng X, Miao YL, Zhou B, Han L, Fargo DC, et al: INO80
facilitates pluripotency gene activation in embryonic stem cell
self-renewal, reprogramming, and blastocyst development. Cell Stem
Cell. 14:575–591. 2014. View Article : Google Scholar : PubMed/NCBI
|
